Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERASE: Rifamycin SV-MMX vs Ciprofloxacin in Traveler's Diarrhea
NCT01208922Phase 3Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Nov 2010
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of rifaximin in traveler's diarrhea (TD), sponsored by Dr. Falk Pharma GmbH. Started Nov 2010; status: completed.
02
Drugs
rifaximin
03
Conditions
traveler's diarrhea (TD)
Beyond the preview
Go deeper on NCT01208922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01208922.